Genenta Science completed its Acquisition of 100% of A.T.C. in May 2026 while moving from biotechnology toward an industrial consolidator model. For investors, the stated strategy now targets majority or full ownership of established Italian companies across aerospace, defense, national security and biotechnology/biosecurity.

Key Highlights

  • Genenta Science holds a 19.9% Equity interest in aerospace and defense company Sòphia High Tech.
  • A performance-driven second Tranche could lift Genenta Science’s Sòphia High Tech ownership to an aggregate 51%.
  • Genenta Science completed the acquisition of 100% of A.T.C. S.r.l.

Genenta Science S.p.A. (NASDAQ: GNTA) completed the acquisition of 100% of A.T.C. S.r.l. In May 2026 as it shifts from biotechnology toward a strategic industrial consolidator. Genenta intends to integrate those businesses into a transparent Nasdaq-listed platform.

Genenta Builds Aerospace and Security Portfolio

A performance-driven second tranche is contemplated that would raise Genenta’s ownership in Sòphia High Tech to an aggregate 51%. Genenta is also pursuing revised industry classifications to reflect its changing Business profile. Proposed alignments include FactSet Industry Classification 4420, ICB classification 50,201,010 and NAICS classification 336,411, with revisions possible as acquisitions, Revenue mix and classification methodologies change.